BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27572089)

  • 1. Quercetin-Decorated Curcumin Liposome Design for Cancer Therapy: In-Vitro and In-Vivo Studies.
    Ravichandiran V; Masilamani K; Senthilnathan B; Maheshwaran A; Wong TW; Roy P
    Curr Drug Deliv; 2017; 14(8):1053-1059. PubMed ID: 27572089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
    Wang WY; Cao YX; Zhou X; Wei B
    Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
    [No Abstract]   [Full Text] [Related]  

  • 3. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
    Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
    J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.
    Aravind SR; Krishnan LK
    Int Immunopharmacol; 2016 May; 34():78-85. PubMed ID: 26927614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Modulates Glycolytic Metabolism and Inflammatory Cytokines via Nrf 2 in Dalton's Lymphoma Ascites Cells In Vivo.
    Das L; Vinayak M
    Anticancer Agents Med Chem; 2018; 18(12):1779-1791. PubMed ID: 29866021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma.
    Ng ZY; Wong JY; Panneerselvam J; Madheswaran T; Kumar P; Pillay V; Hsu A; Hansbro N; Bebawy M; Wark P; Hansbro P; Dua K; Chellappan DK
    Colloids Surf B Biointerfaces; 2018 Dec; 172():51-59. PubMed ID: 30134219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.
    Ma Q; Qian W; Tao W; Zhou Y; Xue B
    Drug Des Devel Ther; 2019; 13():4021-4033. PubMed ID: 31819373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
    Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
    Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
    Shnaikat SG; Shakya AK; Bardaweel SK
    Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel dipeptide nanoparticles for effective curcumin delivery.
    Alam S; Panda JJ; Chauhan VS
    Int J Nanomedicine; 2012; 7():4207-22. PubMed ID: 22915849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems.
    Jelezova I; Drakalska E; Momekova D; Shalimova N; Momekov G; Konstantinov S; Rangelov S; Pispas S
    Eur J Pharm Sci; 2015 Oct; 78():67-78. PubMed ID: 26159739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-chitosan Coated Quercetin Liposomes for Targeted Cancer Therapy.
    Chang CH; Han DE; Ji YY; Wang MY; Li DH; Xu ZL; Li JH; Huang SN; Zhu XL; Jia YY
    Curr Pharm Biotechnol; 2024; 25(7):924-935. PubMed ID: 37861012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives.
    Karewicz A; Bielska D; Loboda A; Gzyl-Malcher B; Bednar J; Jozkowicz A; Dulak J; Nowakowska M
    Colloids Surf B Biointerfaces; 2013 Sep; 109():307-16. PubMed ID: 23668985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
    Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
    AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.